Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (211-220 of 403) with videos related to

Pageof 41
Sort By:
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Current Research in Translational Medicine|April 20, 2025
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantation (WBMT)Eddie Hp Tan, Mahmoud Aljurf, Fazal Hussain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide ConditioningJeannine S McCune, Tao Wang, Khalid Bo-Subait, et al.
Cytotherapy|August 6, 2025
Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle eastAmr Hanbali, Fahad Bahkali, Farhatullah Syed, et al.
Bone Marrow Transplantation|January 15, 2022
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Hematology/Oncology and Stem Cell Therapy|May 14, 2013
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group surveyWalid Rasheed, Ardeshir Ghavamzadeh, Rosemarie Hamladji, et al.
American Journal of Hematology|April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Socié Gérard, et al.
Hematology/Oncology and Stem Cell Therapy|August 27, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyondMarcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 41

Showing results (211-220 of 403) with videos related to

Sort By:
Pageof 41
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Current Research in Translational Medicine|April 20, 2025
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantation (WBMT)Eddie Hp Tan, Mahmoud Aljurf, Fazal Hussain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide ConditioningJeannine S McCune, Tao Wang, Khalid Bo-Subait, et al.
Cytotherapy|August 6, 2025
Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle eastAmr Hanbali, Fahad Bahkali, Farhatullah Syed, et al.
Bone Marrow Transplantation|January 15, 2022
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Hematology/Oncology and Stem Cell Therapy|May 14, 2013
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group surveyWalid Rasheed, Ardeshir Ghavamzadeh, Rosemarie Hamladji, et al.
American Journal of Hematology|April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Socié Gérard, et al.
Hematology/Oncology and Stem Cell Therapy|August 27, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyondMarcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 41